Aldena Therapeutics is a startup based in the United States, most recent round Acquired, 1 tracked investor.
Aldena Therapeutics is a company headquartered in the United States. Aldena Therapeutics has been acquired. Brouky records 1 investor associated with the company.
Aldena Therapeutics develops siRNA-based RNA interference therapies for dermatological conditions, focusing on locally delivered treatments for the skin designed for infrequent dosing. The company is now a fully owned subsidiary of Alys Pharmaceuticals.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.